GO:0007026 negative regulation of microtubule depolymerization: Microtubule Stabilization, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0007026 describes any process that stops, prevents, or reduces the frequency, rate, or extent of microtubule depolymerization, often called microtubule rescue or stabilization.
Key molecular players include microtubule-associated proteins (MAPs), plus-end tracking proteins (+TIPs), and tubulin post-translational modifications such as glutamylation.
Negative regulation of microtubule depolymerization is critical for mitotic spindle function, neuronal polarity, and intracellular transport.
Dysregulation of this process is linked to cancer, neurodegeneration, and fibrosis, making it a therapeutic target.
Experimental approaches include live-cell imaging of EB1/EB3, tubulin polymerization assays, and CRISPR-based knockout or knock-in of stabilizing factors.
EDITGENE provides CRISPR services to model microtubule stabilization in disease and development.

Description

Microtubules are dynamic polymers of alpha- and beta-tubulin that switch between growth and shrinkage, a behavior known as dynamic instability. The frequency of transitions from growth to shrinkage (catastrophe) and from shrinkage to growth (rescue) is tightly regulated. GO:0007026, negative regulation of microtubule depolymerization, encompasses processes that inhibit depolymerization, thereby stabilizing microtubules. This regulation is essential for diverse cellular functions, including chromosome segregation, cell motility, and neuronal morphogenesis. Researchers study this term to understand how cells control cytoskeletal dynamics and how its perturbation contributes to disease. For example, glutamylation of tubulin acts as a negative regulator of microtubule growth, influencing depolymerization rates. Similarly, the carboxy-terminal tail of beta-tubulin modulates dynamic instability, affecting rescue frequency. These findings highlight the importance of precise regulation of microtubule depolymerization in health and disease.

negative regulation of microtubule depolymerization At A Glance

GO ID GO:0007026
GO term negative regulation of microtubule depolymerization
Ontology biological_process
Synonym microtubule rescue, microtubule stabilization, negative regulation of microtubule catastrophe
Major function Stabilization of microtubules by preventing depolymerization
Key regulators MAPs, +TIPs, tubulin post-translational modifications
Associated diseases Cancer, neurodegeneration, fibrosis
Research methods Live-cell imaging, tubulin polymerization assays, CRISPR screens

What Is GO:0007026?

According to the Gene Ontology, GO:0007026 negative regulation of microtubule depolymerization is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of microtubule depolymerization. Prevention of depolymerization can result from binding by capping at the plus end (e.g., by interaction with another cellular protein) or by exposing microtubules to a stabilizing drug such as taxol. Synonyms include microtubule rescue, microtubule stabilization, and negative regulation of microtubule catastrophe.

Why Is negative regulation of microtubule depolymerization Important in Cell Biology?

Negative regulation of microtubule depolymerization is fundamental for maintaining cytoskeletal architecture and function. It ensures proper mitotic spindle assembly and chromosome segregation, supports neuronal polarity and transport, and modulates signaling pathways. Dysregulation can lead to aberrant cell division, neurodegeneration, and fibrosis, making it a target for therapeutic intervention.
Controls mitotic spindle dynamics and chromosome segregation.
Regulates neuronal microtubule polarity and axon guidance.
Modulates viral replication, as shown for porcine betacoronavirus PHEV.
Influences cytokine signaling through SOCS3 and MAP1S.
Affected by tubulin post-translational modifications like glutamylation.
Target of stabilizing drugs such as taxol, used in cancer therapy.
Plays a role in radiation-induced pulmonary fibrosis.
Essential for intracellular transport and cell shape.
Involved in Wnt signaling pathways.
Potential target for cancer and antiviral therapies.

What Happens During negative regulation of microtubule depolymerization?

Initiation by Microtubule-Associated Proteins (MAPs)
In simple terms: Proteins bind to microtubules and protect them from falling apart.
MAPs such as MAP1S and tau bind along the microtubule lattice, stabilizing it against depolymerization. MAP1S is involved in SOCS3 regulation of IL-6 signaling, linking microtubule stabilization to cytokine pathways. The carboxy-terminal tail of beta-tubulin also contributes to stabilization by modulating dynamic instability.
Plus-End Capping by +TIPs
In simple terms: Special proteins cap the growing end of microtubules to stop them from shrinking.
Plus-end tracking proteins (+TIPs) recognize growing microtubule ends and can inhibit catastrophe. For example, Kinesin-13 is regulated by Wnt signaling to establish microtubule polarity in neurons, affecting depolymerization. Glutamylation of tubulin acts as a negative regulator of microtubule growth, influencing the balance between growth and shrinkage.
Role of Tubulin Post-Translational Modifications
In simple terms: Chemical tags on tubulin can make microtubules more stable.
Glutamylation is a negative regulator of microtubule growth, and its removal can increase depolymerization. The carboxy-terminal tail of beta-tubulin is a key determinant of dynamic instability, with modifications affecting rescue frequency.
Integration with Cellular Signaling
In simple terms: Signals from outside the cell can change how stable microtubules are.
Sirt1 regulates microtubule dynamics through negative regulation of Plk1 in mitosis, linking metabolic signaling to microtubule stabilization. Wnt signaling establishes microtubule polarity by regulating Kinesin-13, which affects depolymerization.
Pharmacological Stabilization
In simple terms: Drugs like taxol can stabilize microtubules by preventing depolymerization.
Paclitaxel (taxol) binds to microtubules and inhibits depolymerization, leading to cell cycle arrest. However, it can aggravate radiation-induced pulmonary fibrosis via down-regulation of Spry2, highlighting complex in vivo effects.

Key Genes Involved in GO:0007026 negative regulation of microtubule depolymerization

The following genes and proteins are key players in the negative regulation of microtubule depolymerization, based on published literature.
GeneMajor RoleResearch Relevance
MAP1SMicrotubule-associated protein; stabilizes microtubulesLinks to SOCS3/IL-6 signaling
TUBBBeta-tubulin; carboxy-terminal tail regulates dynamic instabilityMutations affect rescue frequency
KIF13AKinesin-13; regulates microtubule depolymerizationWnt signaling in neuronal polarity
SIRT1Deacetylase; regulates Plk1 and microtubule dynamicsMitosis regulation
PLK1Polo-like kinase 1; promotes mitotic progressionTarget of Sirt1 in microtubule regulation
SPRY2Sprouty RTK signaling antagonist 2Down-regulation in radiation-induced fibrosis
TTLLTubulin tyrosine ligase-like; glutamylation enzymesGlutamylation negatively regulates microtubule growth
EB1Plus-end tracking protein; promotes microtubule growthMarker of microtubule dynamics
EB3Plus-end tracking protein; regulates microtubule stabilityImaging of dynamic microtubules
TauMicrotubule-associated protein; stabilizes microtubulesImplicated in neurodegeneration
MAP2Microtubule-associated protein 2; stabilizes dendritic microtubulesNeuronal morphogenesis
MAP4Microtubule-associated protein 4; stabilizes microtubulesCell cycle regulation
CLASPCytoplasmic linker associated protein; promotes rescueMicrotubule stabilization
XMAP215Microtubule polymerase; promotes growthRegulates dynamic instability
KIF2AKinesin-13; depolymerizes microtubulesRegulated by Wnt signaling
StathminMicrotubule destabilizer; promotes depolymerizationOpposes stabilization
SCG10Stathmin-like; regulates neuronal microtubule dynamicsNeuronal development

How Is negative regulation of microtubule depolymerization Regulated?

The negative regulation of microtubule depolymerization is controlled by multiple mechanisms. Sirt1 negatively regulates Plk1 to modulate microtubule dynamics during mitosis. Wnt signaling regulates Kinesin-13 to establish microtubule polarity in neurons. Tubulin glutamylation acts as a negative regulator of microtubule growth, affecting depolymerization. Additionally, the carboxy-terminal tail of beta-tubulin is a key intrinsic regulator of dynamic instability. These pathways integrate extracellular signals with cytoskeletal stability.

negative regulation of microtubule depolymerization and Human Disease

GeneDisease / BiologyPotential Experimental Model
SIRT1Cancer, mitosisKnockout in cancer cell lines
SPRY2Radiation-induced pulmonary fibrosisOverexpression in lung fibroblasts
KIF13ANeurodegenerationKnockout in neurons
MAP1SIL-6 signaling, inflammationKnockout in hepatocytes
TUBBCancer, drug resistancePoint mutations in tubulin
Cancer
Microtubule-stabilizing agents like paclitaxel are used in cancer therapy, but resistance can arise. Dysregulation of microtubule depolymerization contributes to aberrant mitosis and tumor progression. Sirt1 and Plk1 are potential targets for modulating microtubule dynamics in cancer.
Neurodegeneration
Proper microtubule stabilization is crucial for neuronal function. Wnt signaling regulates Kinesin-13 to establish microtubule polarity, and its disruption may contribute to neurodegenerative diseases. Tau, a microtubule-associated protein, is implicated in Alzheimer's disease.
Fibrosis
Paclitaxel aggravates radiation-induced pulmonary fibrosis via down-regulation of Spry2, highlighting the role of microtubule stabilization in fibrotic responses.
Viral Infection
Microtubule depolymerization limits porcine betacoronavirus PHEV replication, suggesting that stabilizing microtubules may affect viral life cycles.

From negative regulation of microtubule depolymerization-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X stabilize microtubules?Knockout cell line followed by live-cell imaging
Does mutation Y affect depolymerization?Point mutation knock-in
How does gene X affect mitosis?Tagged knock-in for live imaging
Can overexpression of X rescue depolymerization?Overexpression cell line
What pathways interact with X?CRISPR library screening
Does X affect drug sensitivity?Knockout in cancer cells treated with taxol

How to Study the negative regulation of microtubule depolymerization Process

MethodWhat It MeasuresTypical Application
Live-cell imagingMicrotubule dynamics (growth, shrinkage, rescue)Real-time analysis of stabilization
Tubulin polymerization assayPolymerization/depolymerization ratesIn vitro drug testing
CRISPR knockout screenGene essentiality for microtubule stabilityIdentify novel regulators
PhosphoproteomicsSignaling changesPathway analysis
ImmunofluorescenceMicrotubule density and organizationFixed cell analysis
RNA-seqTranscriptional changesResponse to stabilization
Proximity ligation assayProtein-protein interactionsDetect MAP binding
Live-Cell Imaging
Fluorescently labeled tubulin or EB1/EB3 can be used to visualize microtubule dynamics in real time, measuring catastrophe and rescue frequencies.
Tubulin Polymerization Assays
In vitro assays using purified tubulin measure the effect of proteins or drugs on polymerization and depolymerization rates.
CRISPR Screens
Genome-wide knockout screens can identify genes that regulate microtubule stability, using viability or imaging-based readouts.
Proteomics
Mass spectrometry can identify post-translational modifications on tubulin, such as glutamylation, that affect depolymerization.

How CRISPR Can Be Used to Study GO:0007026 negative regulation of microtubule depolymerization

Knockout

CRISPR knockout of genes like SIRT1 or KIF13A can reveal their role in microtubule stabilization. For example, Sirt1 knockout affects Plk1 regulation and mitotic progression.

Point Mutation

Introducing point mutations in tubulin genes (e.g., TUBB) can mimic disease-associated variants and assess their impact on depolymerization.

Knock-in

Tagged knock-in of microtubule-associated proteins (e.g., EB1-GFP) allows live imaging of microtubule dynamics without overexpression artifacts.

Overexpression

Overexpression of stabilizing proteins like MAP1S or Spry2 can test their sufficiency to inhibit depolymerization and rescue phenotypes.

How EDITGENE Supports negative regulation of microtubule depolymerization Research

Researchers studying negative regulation of microtubule depolymerization-related genes often need to determine whether a candidate gene is causally involved in stabilizing microtubules or is merely correlated with changes in dynamics. EDITGENE provides CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of microtubule depolymerization research.

Frequently Asked Questions About negative regulation of microtubule depolymerization

It is any process that stops, prevents, or reduces the frequency, rate, or extent of microtubule depolymerization, often called microtubule rescue or stabilization.
Key genes include MAP1S, TUBB, KIF13A, SIRT1, PLK1, SPRY2, and TTLL enzymes.
Glutamylation acts as a negative regulator of microtubule growth, influencing the balance between growth and shrinkage.
Sirt1 regulates microtubule dynamics through negative regulation of Plk1 in mitosis.
Common methods include live-cell imaging of EB1/EB3, tubulin polymerization assays, and CRISPR screens.
Cancer, neurodegeneration, fibrosis, and viral infections are linked to dysregulation of microtubule depolymerization.
Microtubule rescue is the transition from shrinkage to growth, a key aspect of negative regulation of depolymerization.
Wnt signaling establishes microtubule polarity in neurons through regulation of Kinesin-13.
Yes, taxol stabilizes microtubules by inhibiting depolymerization, but it can have complex effects in vivo.
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes involved in microtubule stabilization.

Conclusion

Negative regulation of microtubule depolymerization (GO:0007026) is a critical biological process that ensures proper cytoskeletal dynamics. Its dysregulation is implicated in cancer, neurodegeneration, and fibrosis. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention. EDITGENE supports researchers with advanced CRISPR models to dissect this process.

References

  1. 1. Chen J et al.. 2023. Glutamylation is a negative regulator of microtubule growth.. Mol Biol Cell 34(7):ar70 PMID: 37074962
  2. 2. Kim JJ et al.. 2015. Sirt1 Regulates Microtubule Dynamics Through Negative Regulation of Plk1 in Mitosis.. J Cell Biochem 116(9):1888-97 PMID: 25737075
  3. 4. Fees CP et al.. 2018. Regulation of microtubule dynamic instability by the carboxy-terminal tail of β-tubulin.. Life Sci Alliance 1(2) PMID: 29963657
  4. 5. Zheng J et al.. 2024. Paclitaxel Aggravating Radiation-Induced Pulmonary Fibrosis Is Associated with the Down-Regulation of the Negative Regulatory Function of Spry2.. J Pharmacol Exp Ther 389(2):197-207 PMID: 37918858
  5. 6. Zhou Q et al.. 2022. Microtubule depolymerization limits porcine betacoronavirus PHEV replication.. Vet Microbiol 269:109448 PMID: 35533578
  6. 7. Puri D et al.. 2021. Wnt signaling establishes the microtubule polarity in neurons through regulation of Kinesin-13.. J Cell Biol 220(9) PMID: 34137792
  7. 8. Zou T et al.. 2008. The role of microtubule-associated protein 1S in SOCS3 regulation of IL-6 signaling.. FEBS Lett 582(29):4015-22 PMID: 19027008
Contact Us
*
*
*
*
How did you hear about us: